Efpeglenatide
AMPLITUDE-D
Sanofi · Phase 3 · Terminated · Enrollment 908
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Efpeglenatide 4 mg | n/r | n/r | n/r | n/r | n/r |
| Efpeglenatide 6 mg | n/r | n/r | n/r | n/r | n/r |
| Dulaglutide 1.5 mg | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.